03 Dec Roche Singapore
Roche Singapore
About the Project
Roche has had a presence in Singapore since 1973 and has since been striving to meet the needs of patients, healthcare professionals and researchers. In Singapore, we have three broad areas of operation: Pharmaceuticals, Diagnostics and Manufacturing.
Roche Technical Operations is a fully-owned Roche subsidiary and was established in Singapore in 2009. With a combined investment of approximately USD500 million, the site is comprised of two state-of-the-art facilities which use two different production technology platforms to manufacture biologic medicines. The facilities occupy approximately 12.6 hectares at the Tuas Biomedical Park.
The Singapore site is an important part of Roche’s global manufacturing network, which includes biotechnology facilities in California (USA), Penzberg (Germany) and Basel (Switzerland). Roche Singapore Technical Operations is expected to be the first company in Singapore to produce licensed biotherapeutics using recombinant DNA technologies.
Brands Used
Please contact our marketing personnel.
Year of Completion
2019